⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Ecolab Focuses On Pest Elimination, Acquires 3 Companies

Published 12/04/2017, 09:12 PM
Updated 07/09/2023, 06:31 AM
MSFT
-
ECL
-
IDXX
-
LMNX
-
PETS
-

Ecolab Inc. (NYSE:ECL) recently announced the acquisition of three U.S. pest services companies that provide specialized capabilities in food storage. The transactions are worth $36 million and were closed on Dec 1.

The acquired companies are Food Protection Services LLC, Royal Pest Solutions, Inc. and Research Fumigation Company, LLC. The latest development expands Ecolab’s pest elimination solutions for the food and beverage industry.

Food Protection operates in the Pacific Northwest, Great Lakes, Midwest and the Mississippi Delta. Royal Pest Solutions functions in the Mid-Atlantic region from New Jersey to South Carolina. Research Fumigation Company serves the Gulf Coast states of Texas, Louisiana, Mississippi, Alabama and Florida.

The acquisitions are expected to boost Ecolab’s offerings in the food and beverage markets by strengthening the Global Services and Specialty business segment. Other terms of the deals have been kept under wraps.

Acquisitions to Boost Growth

Ecolab continues to focus on investment in key growth businesses and bolt-on acquisitions to gain market traction and boost profits and inorganic growth.

In September, the company signed an agreement to acquire the paper chemicals business of Georgia-Pacific. The deal will enhance Ecolab’s position in the growing Tissue and Towel, as well as the Packaging and Board segments of the paper industry.

Earlier, Ecolab, Trucost and Microsoft (NASDAQ:MSFT) had initiated a strategic collaboration to introduce Water Risk Monetizer, the industry’s first publicly available financial modeling tool that allows businesses to understand the impact of water risks (sustainability of water).

Of the other notable tie-ups in the recent past, Ecolab took over Jianghai Environmental Protection Co. Ltd., an industrial water treatment company headquartered in Changzhou, China.

Shares Shine Bright

Year to date, Ecolab has returned almost 18.1%, higher than the broader industry’s 15.9%. The company continues to see improvement in underlying sales volume and pricing across most business segments.

A solid portfolio, product launches and expanding customer base should drive organic sales while the realization of targeted synergies associated with acquisitions should drive margins. Furthermore, solid performance by the Global Institutional segment is encouraging. Sales increased 6.6% to $1.22 billion at the segment in the last quarter, led by strong growth in the Specialty and Healthcare business lines.

Zacks Rank & Key Picks

Ecolab has a Zacks Rank #3 (Hold).

A few better-ranked stocks in the broader medical sector are PetMed Express (NASDAQ:PETS) , Luminex Corporation (NASDAQ:LMNX) and IDEXX Laboratories (NASDAQ:IDXX) .

Notably, PetMed Express sports a Zacks Rank #1 (Strong Buy). The company has a long-term expected earnings growth rate of 10%. You can see the complete list of today’s Zacks #1 Rank stocks here

Luminex yielded a return of 6.4% over the last year. The stock has a Zacks Rank #1.

IDEXX Laboratories has a long-term expected earnings growth rate of 19.8%. The stock has climbed 39.2% over a year’s time and has a Zacks Rank #2 (Buy).

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



PetMed Express, Inc. (PETS): Free Stock Analysis Report

Ecolab Inc. (ECL): Free Stock Analysis Report

Luminex Corporation (LMNX): Free Stock Analysis Report

IDEXX Laboratories, Inc. (IDXX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.